Document is current
Any future updates will be listed below
-
Authors
Liu, Haiyan E.
Vuppalapaty, Meghah
Hoerner, Christian R.
Bergstrom, Colin P.
Chiu, Michael
Lemaire, Clementine
Che, James
Kaur, Amanpreet
Dimmick, Adam
Liu, Sean
Metzner, Thomas J.
Araya, Menna
Crouse, Steve
Sprenger-Haussels, Markus
Schlumpberger, Martin
Leppert, John T.
Hauch, Siegfried
Sollier, Elodie
Fan, Alice C.
-
Funding
Funding for this research was provided by:
Vortex Biosciences
- License Information
-
More Information
Article History
Received: 21 June 2023
Accepted: 18 March 2024
First Online: 16 April 2024
Declarations
:
: Informed consent was obtained from all the participants and/or legal guardians for the study. The study was approved by the Stanford University Institutional Review Board IRB (protocols #5630 and #12597) and allowed for the collection and analysis of blood samples and associated clinico-demographic data. All methods were carried out in accordance with relevant guidelines and regulations, including institutional guidelines and regulations and the World Medical Association’s Declaration of Helsinki.
: Not applicable.
: H. E. L., M. V., M. C., C. L., J. C., A. D., S. L., S. C., and E. S. have financial interests in Vortex Biosciences. J.C. and E. S. have interests in the intellectual property described herein for Vortex Biosciences technology. M. S. H., M. S., and S. H. have financial interests in QIAGEN GmbH and interests in the intellectual property described for the QIAGEN AdnaTest. C. R. H., C. P. B., A. K., T. J. M., M. A., J. T. L., and A. C. F. have no competing interests.
